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abnormalities and their role in the natural history of OA. This work
is also evolving. The key intra-articular structures associated with
knee pain appear to be BML and synovitis. Cartilage loss has
also been weakly associated with knee pain, perhaps through
associations with other tissue abnormalities. In terms of structural
joint deterioration, large cohorts have evaluated rates of cartilage
loss at the knee and the predictive factors for this; certainly
weight-bearing portions have been demonstrated to have more
rapid progression of cartilage loss. The importance of meniscal
degeneration and extrusion in progressive cartilage loss has also
been demonstrated. BML have been associated with high rates of
radiographic OA progression in the ipsilateral knee compartment.
The progressive advances in MRI hardware and software mean
not only better definition of pathology and clearer quantification
of, for example, cartilage, but also improved ability to under-
standing functional response of tissue in vivo, for example, by
looking at proteoglycan loss in cartilage using techniques such
as dGEMRIC.
For clinicians, MRI has brought understanding but as yet little
help. Understanding of the crucial early pathology of menisci or
hyaline cartilage may soon change when we consider applying
the label of OA, and allow us to define ‘early’ OA. A study
demonstrating peri-articular causes of knee pain (eg anserine
bursitis) highlights the continued importance of adequate clinical
assessment. Certainly MRI allows us to define OA subsets, but
there are very limited data on how this information can currently
help clinicians; this will certainly change over the next few years.
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DESTRUCTIVE AND NON-DESTRUCTIVE
AGGRECANOLYSIS IN HUMAN OSTEOARTHRITIS
John Sandy
Our understanding of aggrecanolysis in the human knee joint
has recently been clarified by detailed biochemical analysis of
naturally occurring aggrecan products [1] and confocal imaging
of the human aggrecanases (ADAMTS 1, 4, 5, 8, 9, 15) [2]. In this
presentation, data will be described which shows that ADAMTS5
is unique among the aggrecanases in that it forms complexes
with hyaluronan in cartilage of murine OA models and in both
human post-injury and late-stage human OA cartilages. This find-
ing,which has been established with both fluorescence colocal-
ization imaging and biochemical analysis of extracts, along with
the marked increases in ADAMTS5 protein abundance in human
OA cartilages, indicate that ADAMTS5 is primarily responsible
for destructive aggrecanolysis at Glu392-Ala393 (to generate
G1-NITEGE) in human joint disease. In contrast, one or more
MMPs appears to be responsible for non-destructive cleavage
of aggrecan at Asn360-Phe361 to generate G1-VDIPEN360.
These findings, along with recent studies in MMP-9-null and
ADAMTS-5 null mice, suggest that ADAMTS5-mediated aggre-
canolysis is destructive to murine and human cartilage function,
whereas MMP-mediated aggrecanolysis is non-destructive. In-
stead, MMP-mediated aggrecanolysis may be required to main-
tain normal aggrecan composition and organization [3].
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PAIN SEVERITY SCORING SYSTEM IN OSTEOARTHRITIS
(OA)
Gillian Hawker
Objectives: Despite the importance of pain in OA, little is known
about the quality and characteristics of OA pain, or how these
change over time as the disease progresses. An international
OMERACT/OARSI working group was created in 2004 to develop
pain, physical function and structure states that represent the
progression from early to late disease for individuals with hip and
knee OA. The objective of the pain group was to examine the
pain experience of people with hip/knee OA from early to late
disease to inform the development of a new pain measure for
OA.
Methods: A two-part study, comprised of focus groups and
completion of a standardized questionnaire, was performed in
individuals with a range of levels of pain severity and duration
of hip and/or knee OA symptoms, across 6 centers. English-
speaking men and women with OA aged 40+ years and who
experienced pain on most days of at least one month in the past
year were invited to participate. Focus group methods were stan-
dardized and conducted separately in people with mild, moderate
and severe pain, in men and women, and in individuals with hip
versus knee OA. Each focus group, comprised of up to 8 partici-
pants, used a "funnel approach" starting with broad open-ended
questions regarding the characteristics of the hip/knee symp-
toms over time, and then increasingly focused on more specific
issues, including those aspects of the symptoms they found most
distressing. Focus groups were audio taped and transcribed ver-
batim into Microsoft Word. Content analysis was performed to
identify distinct themes. A modification of Ruta et al’s Patient
Generated Index (PGI) was used to assess the priorities and
concerns of individuals living with hip or knee OA pain, and the
varying weights and values that they attach to their concerns.
The PGI is comprised of 3 parts: Part 1 - participants identified
aspects of their OA pain/symptoms that they considered most
distressing. Part 2 - participants were asked to rate how far they
were from their ideal in each of the chosen areas on a 7-point
Likert scale. Part 3 - participants weighed the relative importance
of the different areas for their overall quality of life. Content anal-
ysis was performed to identify consistent responses and trends
over time (from early to late disease) in the pain/symptom ele-
ments identified as most distressing. Using both focus group and
PGI derived data an OA pain/symptom severity scoring system
was developed and evaluated in existing cohorts of people with
hip/knee OA for reliability and validity against existing OA pain
measures.
Results: Preliminary results suggest there are no clear pat-
terns of change in symptoms over time. Hip symptoms appear
to progress more rapidly than do knee symptoms, and are
described as more distressing. Night pain was described in in-
dividuals with only a short duration of symptoms as often as
for those with long-standing complaints, but worsened with in-
creased duration of disease. Two types of pain were evident - a
background ache or discomfort that was present most of the time
and a more intense but short lived pain which limited activities.
Final results from focus groups and interviews will be presented,
together with results from evaluation of the new pain/symptom
OA measure.
